MEDIROM Healthcare Technologies Inc ADR (MRM) saw an uptrend of 10.23% in the recent trading with $2.37 being its most recent. The current price level -55.28% lower than the highest price of $5.30 marked by the stock while trading over the past 52-weeks, whereas it is 596.44% higher than the lowest price of $0.34 the company dropped to over past 52-weeks. The latest news story on MRM appeared in (GlobeNewswire) under the title “Series A Round Valuation: ¥9 Billion: MEDIROM MOTHER Labs Inc. Decides to Make an Investment from Internal Investors”.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.
MEDIROM Healthcare Technologies Inc ADR Earnings – What Happened With MRM
Coming around sales and income figures on MRM Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
MEDIROM Healthcare Technologies Inc ADR – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 7.90 million. MRM does have institutional investors; and they hold 0.98% of the stock.
As on 2024-06-30, UBS GROUP AG was the top most holder in MEDIROM Healthcare Technologies Inc ADR (NASDAQ:MRM) with an ownership of 30.0 shares of the company or 0.0006 of the stake worth $118.0. The filing also reveals BANK OF AMERICA CORP /DE/ as the second largest holder in the company with a control over 0.0005 of the outstanding shares. Its stake is worth $98.0 for having 25.0 shares in hand.
Key Metrics for MRM
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, MEDIROM Healthcare Technologies Inc ADR has a debt to equity ratio of 3.49.
